Alice Flaherty is a Neurology physician affiliated with Harvard University. OpenAlex indexes 54 publications with 4,139 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
15 Parkman St
Wac 835
Boston, MA 021143117
Telephone
617-724-9234Registry record last updated 8 Jul 2007.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
94.6%Atypical Antipsychotic21.6%Clozapine48%Nuplazid30%Aripiprazole9%Quetiapine Fumarate7%Olanzapine3%Rexulti3%Part D<11 patientsAromatic Amino Acid Decarboxylation Inhibitor20.1%Carbidopa-Levodopa46%Rytary45%Carbidopa-Levodopa Er9%Part D<11 patients+ 24 more classes in this area
Genitourinary & hormones
2.6%beta3-Adrenergic Agonist1.9%Myrbetriq100%Part D≥12 patientsCholinergic Muscarinic Antagonist0.7%Solifenacin Succinate100%Part D<11 patientsHormonal (systemic)
1.6%Mineralocorticoids1.6%Fludrocortisone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1992–2002 per NIH RePORTER. The latest:
- Basal ganglia fMRI in normal and Parkinsonian patients
Massachusetts General Hospital
FY2002$129,951K08NS002067 - Basal ganglia fMRI in normal and Parkinsonian patients
Massachusetts General Hospital
FY2001$129,951K08NS002067 - BASAL GANGLIA FMRI IN NORMAL AND PARKINSONIAN PATIENTS
Massachusetts General Hospital
FY2000$113,751K08NS002067
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Case 38-2023: A 68-Year-Old Woman with Abnormal Movements and Confusion
New England Journal of Medicine
2023 - Cautionary notes on diagnosing functional neurologic disorder as a neurologist-in-training
Neurology Clinical Practice
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Antin, MD
Harvard University
Sarah Fortune, MD
Harvard University
Elizabeth Buchbinder, MD
Harvard University
Ethan Lerner, MD
Harvard University
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”